Ribbon Health vs Becton Dickinson

Side-by-side comparison of AI visibility scores, market position, and capabilities

Becton Dickinson leads in AI visibility (79 vs 35)
Ribbon Health logo

Ribbon Health

EmergingHealthTech

Provider Data API

Ribbon Health provides an API for accurate, real-time provider data — physician directories, insurance acceptance, and location details — helping health plans and apps build reliable care navigation.

AI VisibilityBeta
Overall Score
D35
Category Rank
#543 of 596
AI Consensus
82%
Trend
stable
Per Platform
ChatGPT
39
Perplexity
38
Gemini
40

About

Ribbon Health aggregates and continuously cleans provider data — physician names, specialties, practice locations, insurance plans accepted, and availability — and delivers it through an API that health technology companies, payers, and health systems use to build accurate provider directories and care navigation tools. The core problem Ribbon solves is that provider data decays rapidly as doctors change practices, update insurance contracts, and open or close locations, making directory accuracy a persistent challenge across the industry.

Full profile
Becton Dickinson logo

Becton Dickinson

LeaderHealthcare Tech

Enterprise

Franklin Lakes NJ medical technology (NYSE: BDX) at $21.8B FY2025 revenue (+8.2%); $17.5B Reverse Morris Trust spinoff with Waters (2025), Edwards critical care acquisition $4.2B (2024) competing with Baxter for infusion systems.

AI VisibilityBeta
Overall Score
B79
Category Rank
#25 of 596
AI Consensus
77%
Trend
stable
Per Platform
ChatGPT
76
Perplexity
82
Gemini
84

About

Becton, Dickinson and Company (BD) is a Franklin Lakes, New Jersey-based global medical technology company — publicly traded on the New York Stock Exchange (NYSE: BDX) as an S&P 500 Health Care component — manufacturing and selling medical supplies, devices, laboratory equipment, and diagnostic products through approximately 74,000 employees serving healthcare institutions, clinical laboratories, pharmaceutical companies, and life science researchers in over 190 countries. In fiscal year 2025 (ended September 30, 2025), BD reported full-year revenue of $21.8 billion (up 8.2% year-over-year) with Q4 FY2025 revenue of $5.9 billion (+8.3% reported, +3.9% organic growth), and declared a quarterly dividend of $1.05 per share (+1%). Founded in 1897 in New York City by Maxwell Becton and Fairleigh Dickinson Sr. as a thermometer and surgical instrument maker, BD has grown through 125+ years of acquisitions to become a Fortune 500 ($21.8B revenue, #211 on 2024 Fortune 500) global medtech leader. The company operates through three segments: BD Medical (~50% of revenue, IV catheters, syringes, prefillable drug delivery systems, and medication management solutions), BD Life Sciences (flow cytometry, microbiology, molecular diagnostics, and lab automation), and BD Interventional (advanced patient monitoring, interventional cardiology, and peripheral vascular interventions). BD invests $1.2+ billion annually in R&D. In 2024, BD acquired Edwards Lifesciences' critical care monitoring unit for $4.2 billion.

Full profile

AI Visibility Head-to-Head

35
Overall Score
79
#543
Category Rank
#25
82
AI Consensus
77
stable
Trend
stable
39
ChatGPT
76
38
Perplexity
82
40
Gemini
84
40
Claude
84
33
Grok
77

Key Details

Category
Provider Data API
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Ribbon Health
Provider Data API

Integrations

Only Becton Dickinson
Becton Dickinson is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.